Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.


Explore the 2024 IDC MarketScape excerpt to gain insights into IQVIA's flexible DCT approaches for life sciences companies. This comprehensive report highlights the exceptional strengths of our portfolio, featuring purpose-built DCT technologies such as eCOA, eConsent, Study Hub, telemedicine, connected devices, and services like labs and home health nursing.
Our integrated strategy enables customers to adopt, run, and execute decentralized trial approaches, delivering a unique and differentiating experience.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.